Sign In
Buy LLY
$1,169.86
+53.75 (+4.82%)
At Close: Aug 05, 2026
How LLY Stock Delivered $47 Billion To Shareholders
09:50am, Wednesday, 15'th Oct 2025
In the last decade, Eli Lilly stock (NYSE: LLY) has returned $47 billion to its shareholders via dividends and buybacks. This shareholder-centric approach has delivered solid results in 2025, with the
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with ins
New to Investing? These Are 3 Solid Blue Chip Stocks You Can Build Your Portfolio Around
03:30am, Wednesday, 15'th Oct 2025
Getting started with investing can be overwhelming. There are many solid stocks to choose from, but also many risky ones you'll probably be better off avoiding.
1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today
08:05pm, Tuesday, 14'th Oct 2025
Eli Lilly (LLY -0.82%) has been one of the best-performing healthcare giants over the past decade. It now stands as the largest in the sector by market cap.
Independence Bank of Kentucky Buys Another $3.1 Million Eli Lilly (NYSE: LLY) Shares
03:22pm, Tuesday, 14'th Oct 2025
Independence Bank of Kentucky disclosed a purchase of 4,193 shares of Eli Lilly and Company (NYSE: LLY), estimated at $3.12 million based on the average price for the quarter, in its SEC filing for th
Wall Street Breakfast Podcast: Papa John's Delivers A Hot Slice
07:49am, Tuesday, 14'th Oct 2025
Papa John's (PZZA) surged nearly 10% after reports of a $64/share takeover bid from Apollo Global. PZZA is up 3% premarket.
Eli Lilly: The Rally Has More Room To Run (Rating Upgrade)
10:51am, Monday, 13'th Oct 2025
Eli Lilly stock has recovered resoundingly, outperforming the S&P 500, Novo Nordisk, and healthcare peers after a period of decline. LLY's robust pipeline, expansion into cardiometabolic and oncology
Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval
10:47am, Monday, 13'th Oct 2025
Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an aid in the initial assessment for Alzheimer's disease.
Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
10:10am, Monday, 13'th Oct 2025
As the largest publicly traded U.S. healthcare enterprise, Eli Lilly & Co. (NYSE:LLY) has historically offered investors a reliable avenue for growth. Indeed, this narrative has been particularly powe
Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral presentati
Aspen wins approval to market Lilly's Mounjaro for weight loss in South Africa
05:26am, Monday, 13'th Oct 2025
South Africa's Aspen Pharmacare said on Monday it had secured regulatory approval to market Eli Lilly's blockbuster diabetes and obesity drug, Mounjaro, for chronic weight management in the country.
Should Investors Buy Eli Lilly Stock?
07:00am, Saturday, 11'th Oct 2025
Eli Lilly (LLY -2.60%) shares jumped in the last month as investors gained confidence in its pipeline of products.
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
10:15am, Friday, 10'th Oct 2025
Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to lower drug prices
2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now
06:45am, Friday, 10'th Oct 2025
There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well. Since they belong to a defensive industry, drugmakers tend to perform better t
A Pricing Powerhouse, Now 30% Cheaper: Is Eli Lilly Stock A Buy?
10:15am, Thursday, 09'th Oct 2025
Eli Lilly (LLY) stock merits your attention. Why? Because it offers monopoly-like high margins at a reduced price.
